Compare NNNN & NCNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NNNN | NCNO |
|---|---|---|
| Founded | 2021 | 2011 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | N/A | 2022 |
| Metric | NNNN | NCNO |
|---|---|---|
| Price | $23.79 | $13.99 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 17 |
| Target Price | N/A | ★ $31.79 |
| AVG Volume (30 Days) | 26.3K | ★ 1.8M |
| Earning Date | 04-28-2026 | 03-31-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 13.16 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $540,657,000.00 |
| Revenue This Year | N/A | $11.87 |
| Revenue Next Year | N/A | $7.86 |
| P/E Ratio | $446.57 | ★ N/A |
| Revenue Growth | N/A | ★ 13.45 |
| 52 Week Low | $5.91 | $13.80 |
| 52 Week High | $55.65 | $33.92 |
| Indicator | NNNN | NCNO |
|---|---|---|
| Relative Strength Index (RSI) | 52.80 | 33.74 |
| Support Level | $19.53 | $13.80 |
| Resistance Level | $30.70 | $17.08 |
| Average True Range (ATR) | 1.97 | 0.76 |
| MACD | 0.41 | 0.06 |
| Stochastic Oscillator | 84.48 | 8.96 |
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
Ncino Inc is a provider of cloud-based software for financial institutions. Its software solution digitizes, automates, and streamlines inefficient and complex processes & workflows and utilizes data analytics & artificial intelligence that enables financial institutions to onboard new clients, make loans, and manage the entire loan life cycle, open deposits, and other accounts, and manage regulatory compliance. It also offers professional services, including configuration & implementation, training, and advisory services. The company generates the majority of its revenue from subscription services. The company caters to financial institutions, enterprise banks, regional banks, community banks, and credit unions. The vast majority of its revenue comes from the United States.